ROYAL BANK OF CANADA - CHINA BIOLOGIC PRODS INC ownership

CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 6 filers reported holding CHINA BIOLOGIC PRODS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q2 2017$16,034,000
+12.9%
141,774
-0.0%
0.01%0.0%
Q1 2017$14,198,000
-6.9%
141,787
-0.1%
0.01%0.0%
Q4 2016$15,255,000
-13.6%
141,879
+0.0%
0.01%
-20.0%
Q3 2016$17,659,000
+81.4%
141,863
+55.0%
0.01%
+66.7%
Q2 2016$9,733,000
+243225.0%
91,549
+326860.7%
0.01%
Q4 2015$4,000
-76.5%
28
-88.8%
0.00%
Q4 2014$17,000
+30.8%
2500.0%0.00%
Q3 2014$13,000
+225.0%
250
+150.0%
0.00%
Q2 2014$4,0001000.00%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q3 2017
NameSharesValueWeighting ↓
SPQ Asia Capital Ltd 287,277$35,760,00028.32%
WARBURG PINCUS LLC 6,674$830,780,00013.45%
Ariose Capital Management Ltd 238,841$27,689,0007.56%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 12,600$1,568,0004.48%
RUDMAN ERROL M 37,001$4,606,0003.72%
INDUS CAPITAL PARTNERS, LLC 245,237$30,527,0002.89%
Ativo Capital Management LLC 93,784$11,674,0002.70%
OBERWEIS ASSET MANAGEMENT INC/ 63,305$7,880,0002.27%
Point72 Hong Kong Ltd 31,500$3,921,0002.14%
Cormorant Asset Management, LP 112,867$14,050,0001.55%
View complete list of CHINA BIOLOGIC PRODS INC shareholders